Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Using related donors other than genotypically HLA-matched siblings in allogeneic hematopoietic stem cell transplantation for hematologic disease: a single institution experience in Japan.
Tomonari A, Iseki T, Ooi J, Takahashi S, Ishii K, Takahashi T, Shindo M, Nagamura F, Uchimaru K, Nagayama H, Shirafuji N, Tojo A, Tani K, Asano S. Tomonari A, et al. Among authors: takahashi t, takahashi s. Int J Hematol. 2002 Nov;76(4):354-9. doi: 10.1007/BF02982696. Int J Hematol. 2002. PMID: 12463600 Clinical Trial.
Second allogeneic hematopoietic stem cell transplantation for leukemia relapse after first allogeneic transplantation: outcome of 16 patients in a single institution.
Tomonari A, Iseki T, Ooi J, Nagayama H, Sato H, Takahashi T, Ito K, Nagamura F, Uchimaru K, Takahashi S, Shirafuji N, Tojo A, Tani K, Asano S. Tomonari A, et al. Among authors: takahashi t, takahashi s. Int J Hematol. 2002 Apr;75(3):318-23. doi: 10.1007/BF02982050. Int J Hematol. 2002. PMID: 11999364
A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukaemia in complete remission.
Ooi J, Iseki T, Takahashi S, Tomonari A, Nagayama H, Ishii K, Ito K, Sato H, Takahashi T, Shindo M, Sekine R, Ohno N, Uchimaru K, Nagamura F, Shirafuji N, Tojo A, Tani K, Asano S. Ooi J, et al. Among authors: takahashi t, takahashi s. Br J Haematol. 2002 Jul;118(1):140-3. doi: 10.1046/j.1365-2141.2002.03650.x. Br J Haematol. 2002. PMID: 12100139 Free article.
Factors prognostic of eligibility for allogeneic HCT among older patients with AML-CR1 and adverse- or intermediate-risk cytogenetics.
Yamasaki S, Yoshimoto G, Ogawa R, Aoki K, Higuchi M, Harada N, Arima F, Kondo S, Matubara F, Takahashi T, Uike N, Miyamoto T, Okamura S, Akashi K; Fukuoka Blood and Marrow Transplantation Group. Yamasaki S, et al. Among authors: takahashi t. Ann Hematol. 2015 Jul;94(7):1159-65. doi: 10.1007/s00277-015-2338-7. Epub 2015 Feb 24. Ann Hematol. 2015. PMID: 25704584
Adverse Events Associated With Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study.
Ikeda K, Ohto H, Okuyama Y, Yamada-Fujiwara M, Kanamori H, Fujiwara SI, Muroi K, Mori T, Kasama K, Iseki T, Nagamura-Inoue T, Fujii N, Ashida T, Kameda K, Kanda J, Hirose A, Takahashi T, Nagai K, Minakawa K, Tanosaki R. Ikeda K, et al. Among authors: takahashi t. Transfus Med Rev. 2018 Jun 1:S0887-7963(18)30023-3. doi: 10.1016/j.tmrv.2018.05.005. Online ahead of print. Transfus Med Rev. 2018. PMID: 29891441 Free article. Review.
Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation.
Ikeda T, Mori K, Kawamura K, Mori T, Hagiwara S, Ueda Y, Kahata K, Uchida N, Tsukada N, Murakami S, Yamamoto M, Takahashi T, Ichinohe T, Onizuka M, Atsuta Y, Kanda Y, Okamoto S, Sunami K, Takamatsu H. Ikeda T, et al. Among authors: takahashi t. Hematol Oncol. 2019 Dec;37(5):586-594. doi: 10.1002/hon.2688. Epub 2019 Nov 23. Hematol Oncol. 2019. PMID: 31674032
Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study.
Ikeda K, Ohto H, Yamada-Fujiwara M, Okuyama Y, Fujiwara SI, Muroi K, Mori T, Kasama K, Kanamori H, Iseki T, Nagamura-Inoue T, Kameda K, Kanda J, Nagai K, Fujii N, Ashida T, Hirose A, Takahashi T, Minakawa K, Tanosaki R. Ikeda K, et al. Among authors: takahashi t. Transfusion. 2020 May;60(5):1015-1023. doi: 10.1111/trf.15786. Epub 2020 Apr 18. Transfusion. 2020. PMID: 32306410 Clinical Trial.
Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group.
Saito T, Hatta Y, Hayakawa F, Takahashi T, Hagihara M, Iida H, Minauchi K, Yamazaki E, Sugiura I, Murayama T, Sakura T, Mori N, Imai K, Yahagi Y, Atsuta Y, Saito AM, Hirakawa A, Kiyoi H, Matsumura I, Miyazaki Y; Japan Adult Leukemia Study Group. Saito T, et al. Among authors: takahashi t. Int J Hematol. 2021 Mar;113(3):395-403. doi: 10.1007/s12185-020-03032-3. Epub 2020 Nov 23. Int J Hematol. 2021. PMID: 33230647 Clinical Trial.
14,917 results
You have reached the last available page of results. Please see the User Guide for more information.